Patenting Therapeutic Antibodies: Basics and Beyond
Webinar Playback Time: TBD
Live Meeting Time: September 2nd, Saturday, 9pm-10pm, EST (Sunday, September 3rd, 9 am to 10 am Beijing Time)
Abstract: Intellectual property is an important asset in a company. Well protected patent and trade secrets will provide increased value to a company. Many antibody therapeutic companies use patenting as the strategy to protect their own IP and to prevent from the competition. I will discuss the basic patent in biotechnology. I will also discuss the importance of protecting trade secrets; inventorship and ownership of the inventions. I will also discuss how to identify an antibody invention, what to document and when to talk to an patent expert. The presentation will further discuss what an antibody claim and a therapeutic antibody claim are about with one or two examples of current antibody litigation in US. In a nutshell, the presentation provide a basic understanding of antibody patent protection.
Speaker: Dr. Lin Sun-Hoffman
A founding partner in Liu, Zheng, Chen & Hoffman LLP, Dr. Lin Sun-Hoffman is a patent attorney with 20-year experience focused on innovative life sciences. Lin has deep knowledge in all aspects of patent practices, ranging from policy, patent preparation and prosecution, due diligence, opinion work, through licensing and technology transfer negotiation.
In addition to her patent work, Lin has extensive experience with Chinese regulatory authorities, i.e., the Chinese FDA and the General Administration of Quality Supervision, Inspection and Quarantine (AQSIQ), and broader expertise in US and Chinese government affairs, serving clients ranging from start-up to Fortune-100.
Lin’s diverse background has prepared her to tackle the toughest challenges facing innovative life sciences companies today, starting with her time as a patent examiner at the United States Patent and Trademark Office (USPTO). She left USPTO to serve as managing patent counsel at Celera Genomics before joining the Life Technologies Corporation (formerly Applied Biosystems, now ThermoFisher). She is a frequent speaker in China, the US, and Europe, including participation at the invitation of USPTO to speak at SIPO and WIPO Conferences.
Lin also has over ten years of biomedical research experience including several years as a postdoctoral research fellow with several publications at the National Cancer Institute (NCI) of National Institutes of Health (NIH) in Frederick and Bethesda, Maryland. Lin currently serves as vice chair of LES International University-Industry-Government subcommittee, Bay Area Chapter head for BayHelix, Secretary General of US-China Green Energy Council. Lin was President of the Chinese Bioscience Association in Silicon Valley in 2013, and President of the Chinese Biopharmaceutical Association (CBA) 2008-2009. Lin also served as Chief Advisor for Asia at the Grocery Manufacturers Association (GMA) during 2011-2015, and Chief Advisor for Asia at Biotechnology Industry Organization’s (BIO) during 2009-2011.
Lin is also active in community activities including serving on the PTA executive council board (2015-2017) of Palo Alto School District, and teaches underprivileged students in rural area Yunnan China every summer.
Lin obtained her J.D., from University of Maryland School of Law (Maryland, U.S.); Ph.D. in Biochemistry, Cell and Molecular Biology from the University of Nevada Reno (Nevada, U.S.); and B.S. in Biology, East China Normal University (Shanghai, China). She is admitted in Maryland and U.S. Patent and Trademark Office.
Webinar registration is only open to CAS members.
-Not a member yet? Click Here to become a CAS member first.
– If you’ve have forgotten your password, please Click Here to reset it. This will send the account’s current email a private and temporary link that will allow you to reset your password. If, after a few minutes, the email doesn’t seem to arrive, please be sure to check your junk/spam folders.
– If you’re still having problems, please send an email to email@example.com describing your login issue in detail.
June 24th, 2017|Title: Fundamentals of therapeutic antibody discovery|Speaker: Dr. Zhijian Lu
July 15th, 2017|Title: Cell Line and Upstream Process Development for the Manufacture of Monoclonal Antibodies|Speaker: Dr. Zhong Liu
Aug 5th, 2017|Title: Regulatory and Quality Considerations for the US filing of Monoclonal Antibody and Related Products|Speaker: Dr. Audrey Jia